Availability of Long-Acting Injectable Buprenorphine at Substance Use Treatment Facilities in 2021-Reference-Cited by-同舟云学术

Availability of Long-Acting Injectable Buprenorphine at Substance Use Treatment Facilities in 2021

Published:2024-02-13 Issue:6 Volume:331 Page:524
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Vidyasagar Nitin¹,Bunting Samuel R.²,Arora Vineet M.¹,Ari Mim³

Affiliation:

1. Pritzker School of Medicine, The University of Chicago, Chicago, Illinois

2. Department of Psychiatry & Behavioral Neuroscience, The University of Chicago, Chicago, Illinois

3. Department of Medicine, The University of Chicago, Chicago, Illinois

Abstract

This study assesses the proportion of US substance use and mental health care facilities that offered any medications for opioid use disorder and, specifically, long-acting injectable buprenorphine in 2021.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jama/articlepdf/2814255/jama_vidyasagar_2024_ld_230089_1707775806.7408.pdf

Reference6 articles.

1. Use of medication for opioid use disorder among adults with past-year opioid use disorder in the US, 2021.;Jones;JAMA Netw Open,2023

2. Availability of extended-release buprenorphine to treat opioid use disorders among medicaid-covered patients.;Shover;Psychiatr Serv,2021

3. Buprenorphine treatment for opioid use disorder: comparison of insurance restrictions, 2017–21: study examines insurance restrictions on buprenorphine treatment for opioid use disorder.;Andraka-Christou;Health Aff (Millwood),2023

4. Drug Enforcement Administration. Buprenorphine. Accessed October 31, 2023. https://www.deadiversion.usdoj.gov/drug_chem_info/buprenorphine.pdf

5. Substance Abuse and Mental Health Services Administration. National Substance Use and Mental Health Services Survey (N-SUMHSS), 2021: codebook. Accessed April 17, 2023. https://www.datafiles.samhsa.gov/sites/default/files/field-uploads-protected/studies/N-SUMHSS-2021/N-SUMHSS-2021-datasets/N-SUMHSS-2021-DS0001/N-SUMHSS-2021-DS0001-info/N-SUMHSS-2021-DS0001-info-codebook.pdf

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018–2022;Addiction;2024-08-16